New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2013
17:05 EDTABIO, MDTARCA Biopharma plans new Phase 3 trial for Gencaro
ARCA Biopharma (ABIO) provided an update on a proposed, genetically-targeted clinical trial in atrial fibrillation of the company's lead developmental drug, Gencaro. The company also announced that Medtronic (MDT) has signed a non-binding Letter of Intent to collaborate on the initial, Phase 2B portion of the proposed trial.
News For ABIO;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2015
10:15 EDTMDTThoratec downgraded to Market Perform from Outperform at Northland
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use